The Impact Of Acute Heart Failure Related Length Of Stay On The 30-day All-Cause Readmission Rate.
HFSA ePoster Library. SAFIRIYU I. 09/10/21; 343340; 118
ISRAEL SAFIRIYU
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Abstract
Discussion Forum (0)
Introduction: Iron deficiency (ID) is common in patients with heart failure and negatively impacts quality of life and outcomes. Data recently published from AFFIRM-AHF demonstrated reduction in hospitalization in patients recovered from ADHF who received first dose of iron repletion during inpatient stay. As part of continuous Hospital Readmissions Reduction Program (HRRP) performance improvement efforts, we developed an electronic health record (EHR) screening tool to identify hospitalized patients with heart failure and ID.
Hypothesis: Creation of a EHR tool will lead to identification of patients who may benefit from IV iron repletion therapy to reduce utilization
Methods: Using an existing inpatient EHR census comprised of adults with a history of chronic heart failure, we modeled criteria after AFFIRM-AHF which included EF ≤ 50%, hemoglobin ≤ 13 mg/dL, ferritin ≤ 300 mg/dL and TSAT ≤ 20%. The tool captured patients admitted for ADHF daily over a 2-week period in April 2021 at an urban academic medical center.
Results: During study period, 261 patients were admitted for ADHF and 30 screened positive for ID. Characteristics are described in Table 1. In the 12 months prior to admission, 16.7% of patients had 1 emergency department visit for worsening HF, 23.3% had 1 prior hospitalization for ADHF and 30.0% had 2 or more prior hospitalizations.
Conclusion: An EHR tool easily and accurately identified patients with comorbid ID and HF. Including iron repletion in future inpatient clinical pathways or HRRP efforts may decrease utilization in this subset of patients.
Hypothesis: Creation of a EHR tool will lead to identification of patients who may benefit from IV iron repletion therapy to reduce utilization
Methods: Using an existing inpatient EHR census comprised of adults with a history of chronic heart failure, we modeled criteria after AFFIRM-AHF which included EF ≤ 50%, hemoglobin ≤ 13 mg/dL, ferritin ≤ 300 mg/dL and TSAT ≤ 20%. The tool captured patients admitted for ADHF daily over a 2-week period in April 2021 at an urban academic medical center.
Results: During study period, 261 patients were admitted for ADHF and 30 screened positive for ID. Characteristics are described in Table 1. In the 12 months prior to admission, 16.7% of patients had 1 emergency department visit for worsening HF, 23.3% had 1 prior hospitalization for ADHF and 30.0% had 2 or more prior hospitalizations.
Conclusion: An EHR tool easily and accurately identified patients with comorbid ID and HF. Including iron repletion in future inpatient clinical pathways or HRRP efforts may decrease utilization in this subset of patients.
Introduction: Iron deficiency (ID) is common in patients with heart failure and negatively impacts quality of life and outcomes. Data recently published from AFFIRM-AHF demonstrated reduction in hospitalization in patients recovered from ADHF who received first dose of iron repletion during inpatient stay. As part of continuous Hospital Readmissions Reduction Program (HRRP) performance improvement efforts, we developed an electronic health record (EHR) screening tool to identify hospitalized patients with heart failure and ID.
Hypothesis: Creation of a EHR tool will lead to identification of patients who may benefit from IV iron repletion therapy to reduce utilization
Methods: Using an existing inpatient EHR census comprised of adults with a history of chronic heart failure, we modeled criteria after AFFIRM-AHF which included EF ≤ 50%, hemoglobin ≤ 13 mg/dL, ferritin ≤ 300 mg/dL and TSAT ≤ 20%. The tool captured patients admitted for ADHF daily over a 2-week period in April 2021 at an urban academic medical center.
Results: During study period, 261 patients were admitted for ADHF and 30 screened positive for ID. Characteristics are described in Table 1. In the 12 months prior to admission, 16.7% of patients had 1 emergency department visit for worsening HF, 23.3% had 1 prior hospitalization for ADHF and 30.0% had 2 or more prior hospitalizations.
Conclusion: An EHR tool easily and accurately identified patients with comorbid ID and HF. Including iron repletion in future inpatient clinical pathways or HRRP efforts may decrease utilization in this subset of patients.
Hypothesis: Creation of a EHR tool will lead to identification of patients who may benefit from IV iron repletion therapy to reduce utilization
Methods: Using an existing inpatient EHR census comprised of adults with a history of chronic heart failure, we modeled criteria after AFFIRM-AHF which included EF ≤ 50%, hemoglobin ≤ 13 mg/dL, ferritin ≤ 300 mg/dL and TSAT ≤ 20%. The tool captured patients admitted for ADHF daily over a 2-week period in April 2021 at an urban academic medical center.
Results: During study period, 261 patients were admitted for ADHF and 30 screened positive for ID. Characteristics are described in Table 1. In the 12 months prior to admission, 16.7% of patients had 1 emergency department visit for worsening HF, 23.3% had 1 prior hospitalization for ADHF and 30.0% had 2 or more prior hospitalizations.
Conclusion: An EHR tool easily and accurately identified patients with comorbid ID and HF. Including iron repletion in future inpatient clinical pathways or HRRP efforts may decrease utilization in this subset of patients.
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}